IBDEI1RR ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31629,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,31629,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,31629,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,31630,0)
 ;;=N18.4^^190^1939^15
 ;;^UTILITY(U,$J,358.3,31630,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31630,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,31630,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,31630,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,31631,0)
 ;;=N18.5^^190^1939^16
 ;;^UTILITY(U,$J,358.3,31631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31631,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,31631,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,31631,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,31632,0)
 ;;=Q61.3^^190^1939^78
 ;;^UTILITY(U,$J,358.3,31632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31632,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,31632,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,31632,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,31633,0)
 ;;=R51.^^190^1940^1
 ;;^UTILITY(U,$J,358.3,31633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31633,1,3,0)
 ;;=3^Headache
 ;;^UTILITY(U,$J,358.3,31633,1,4,0)
 ;;=4^R51.
 ;;^UTILITY(U,$J,358.3,31633,2)
 ;;=^5019513
 ;;^UTILITY(U,$J,358.3,31634,0)
 ;;=G44.1^^190^1940^3
 ;;^UTILITY(U,$J,358.3,31634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31634,1,3,0)
 ;;=3^Vascular Headache NEC
 ;;^UTILITY(U,$J,358.3,31634,1,4,0)
 ;;=4^G44.1
 ;;^UTILITY(U,$J,358.3,31634,2)
 ;;=^5003934
 ;;^UTILITY(U,$J,358.3,31635,0)
 ;;=G43.909^^190^1940^2
 ;;^UTILITY(U,$J,358.3,31635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31635,1,3,0)
 ;;=3^Migraine,Unspec,Not Intractable
 ;;^UTILITY(U,$J,358.3,31635,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,31635,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,31636,0)
 ;;=I50.32^^190^1941^4
 ;;^UTILITY(U,$J,358.3,31636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31636,1,3,0)
 ;;=3^Diastolic Heart Failure,Chronic
 ;;^UTILITY(U,$J,358.3,31636,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,31636,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,31637,0)
 ;;=I50.33^^190^1941^3
 ;;^UTILITY(U,$J,358.3,31637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31637,1,3,0)
 ;;=3^Diastolic Heart Failure,Acute on Chronic
 ;;^UTILITY(U,$J,358.3,31637,1,4,0)
 ;;=4^I50.33
 ;;^UTILITY(U,$J,358.3,31637,2)
 ;;=^5007246
 ;;^UTILITY(U,$J,358.3,31638,0)
 ;;=I50.40^^190^1941^8
 ;;^UTILITY(U,$J,358.3,31638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31638,1,3,0)
 ;;=3^Systolic & Diastolic Congestive Heart Failure,Combined Unspec
 ;;^UTILITY(U,$J,358.3,31638,1,4,0)
 ;;=4^I50.40
 ;;^UTILITY(U,$J,358.3,31638,2)
 ;;=^5007247
 ;;^UTILITY(U,$J,358.3,31639,0)
 ;;=I51.7^^190^1941^2
 ;;^UTILITY(U,$J,358.3,31639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31639,1,3,0)
 ;;=3^Cardiomegaly
 ;;^UTILITY(U,$J,358.3,31639,1,4,0)
 ;;=4^I51.7
 ;;^UTILITY(U,$J,358.3,31639,2)
 ;;=^5007257
 ;;^UTILITY(U,$J,358.3,31640,0)
 ;;=I42.6^^190^1941^1
 ;;^UTILITY(U,$J,358.3,31640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31640,1,3,0)
 ;;=3^Alcoholic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,31640,1,4,0)
 ;;=4^I42.6
 ;;^UTILITY(U,$J,358.3,31640,2)
 ;;=^5007197
 ;;^UTILITY(U,$J,358.3,31641,0)
 ;;=I50.1^^190^1941^7
 ;;^UTILITY(U,$J,358.3,31641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31641,1,3,0)
 ;;=3^Left Ventricular Failure
 ;;^UTILITY(U,$J,358.3,31641,1,4,0)
 ;;=4^I50.1
 ;;^UTILITY(U,$J,358.3,31641,2)
 ;;=^5007238
 ;;^UTILITY(U,$J,358.3,31642,0)
 ;;=I50.20^^190^1941^12
 ;;^UTILITY(U,$J,358.3,31642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31642,1,3,0)
 ;;=3^Systolic Heart Failure,Unspec
